The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, producing billions in revenue , its exclusivity period created a deluge of https://rotatesites.com/story22946638/sildenafil-and-the-pharmaceutical-sector-a-uncertain-opportunity